Update on HIV Cure Research and Antiretroviral Drugs and Strategies, and a Personal Experience with COVID-19


Joseph J. Eron, Jr, MD
University of North Carolina at Chapel Hill
Michael S. Saag, MD
University of Alabama at Birmingham


March 26, 2020 - 1:00 PM


March 26, 2020 - 2:30 PM

Add to iCal Calendar
4:00 PM ET; 3:00 PM CT; 2:00 PM MT; 1:00 PM PT
Use this tool to calculate the time of the webinar in your location.

Assessment of Needs

Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on strategies for clinical management.

This is a special web-based update on Virtual CROI 2020 for New York and Atlanta course attendees. The live webinar will highlight data presented at CROI, including:

  • Update on HIV Cure Research
  • Current Understanding of the COVID-19 Pandemic
  • Advances in Antiretroviral Therapy
  • Grab Bag of various other issues, including preexposure prophylaxis, concomitant conditions and opportunistic diseases, and unique populations

Learning Objectives

Upon completion of this webinar, learners will be able to describe selected research presented at vCROI 2020 with regard to:

  • Research on advances toward a cure for HIV
  • A personal experience with COVID-19
  • Findings from clinical trials, treatment, and prevention strategies

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”


Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc and ViiV Healthcare. (Updated 9/30/21)

Dr Eron has served as an ad hoc consultant to Janssen, ViiV Healthcare, Merck & Co, Inc, and Gilead Sciences, Inc. His institution receives contracts for clinical research on which Dr Eron is the local principal investigator from Janssen Therapeutics, ViiV Healthcare, and Gilead Sciences, Inc. (Updated 06/20/20)


Please note that participation in this activity is only available to those who had registered for the New York and Atlanta Annual Update on HIV Management live courses, which have been postponed due to the international COVID-19 pandemic. If you are registered for either live course, you will be automatically registered for the webinar.

Who Should Attend

This advanced webinar is designed for clinical decision makers who are actively involved in HIV care and research. It is also relevant for registered nurses, PharmDs, and other health professionals.

Cancellation Policy

Once we determine the new dates for the in-person courses, your registration will automatically transfer. Your registration fee is fully refundable if you wish to cancel and request a refund. Please note that due to San Francisco’s shelter in place ordinance, it may take a few weeks to process.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

This program is approved for 1.25 hours of pharmacotherapy credit.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.   Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.5 contact hours (0.15 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN  # 0761-9999-20-047-L02-P

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Food and beverages at IAS–USA events are purchased with registration fees, not with grant support money. Generous support for this activity has been received from the following contributors.


Gilead Sciences, Inc
Merck & Co, Inc
ViiV Healthcare


Janssen Therapeutics

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.